Health Blueprint

Masters of Longevity - The Pulse

Feature20 Oct 2026

MOTS-c: Where the Evidence Ends

Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?

MOTS-c: Where the Evidence Ends

By The Peptide Dosing editorial team

Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?

Feature20 Oct 2026
Abstract illustration of mitochondria with folded inner membranes in a cell

Editorial Picks

More from MoL
Conceptual amber glass heart within a translucent teal torso, illustrating an organ within its surrounding body.

How Old Is a Transplanted Heart?

By Marcel Achermann

Science Brief05 Oct 2026

Conceptual biomedical lab scene with AI research-agent panels connecting literature, hypothesis planning and experiment analysis to an automated pipetting station and a scientist at a microscope; not experimental data.

Anthropic’s Claude Phage Finding and the New Pace of Research

By Marcel Achermann

Commentary24 Sept 2026

Three global-health professionals examine a city map and interconnected images of neighbourhoods, services and care settings in a research workspace.

What Global Dementia Risk Models Still Miss

By Marcel Achermann

Science Brief24 Sept 2026

Older woman practising a controlled heel-to-toe balance step beside a sturdy chair at home, with a small unbranded supplement jar on a side table.

Calcium, Vitamin D and Fall Prevention: What the Evidence Changes

By Marcel Achermann

Science Brief22 Sept 2026

Conceptual cross-section of human hippocampal tissue with support cells, microglia-like cells and folded chromatin inside a cell nucleus.

What Changes in the Human Hippocampus with Age?

By Marcel Achermann

Editorial20 Sept 2026

Conceptual glass DNA helix and separate building blocks in a dark laboratory-inspired scene.

Nucleotides and Longevity: Is the Evidence Ready?

By Marcel Achermann

Editorial17 Sept 2026

Trending News

Based on last 48h engagement

  1. 01Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemia (Nature - Biotechn...Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemiaNature - Biotechnology • 23 Oct 2026External link, opens in a new tab
  2. 02Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO (PR Newswire)Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMOPR Newswire • 25 Oct 2026External link, opens in a new tab
  3. 03The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneous... (PR Newswire)The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of MedicinePR Newswire • 25 Oct 2026External link, opens in a new tab
  4. 04Holographic focused ultrasound enables multitarget EV and MSC delivery for neurovascular repair after ischemic stroke (Nature - Biotechnology)Holographic focused ultrasound enables multitarget EV and MSC delivery for neurovascular repair after ischemic strokeNature - Biotechnology • 25 Oct 2026External link, opens in a new tab
  5. 05Urinary succinate is associated with kidney injury in type 2 diabetes mellitus: a cross-sectional analysis (Frontiers - Health)Urinary succinate is associated with kidney injury in type 2 diabetes mellitus: a cross-sectional analysisFrontiers - Health • 26 Oct 2026External link, opens in a new tab

Upcoming Events

View calendar
  1. THE LIVE Barcelona 2026 (Barcelona, Spain)26. OCT 2026 - 28. OCT 2026THE LIVE Barcelona 2026Media PartnerSummit - Barcelona, Spain★
  2. CEE Longevity Summit & Retreat 2026 (Samorin, Slovakia)29. OCT 2026 - 31. OCT 2026CEE Longevity Summit & Retreat 2026Retreat - Samorin, Slovakia
  3. Parkhotel Longevity Retreat — October 2026 (Bad Bayersoien, Germany)31. OCT 2026 - 8. NOV 2026Parkhotel Longevity Retreat — October 2026Retreat - Bad Bayersoien, Germany
  4. Biology of Aging Symposium V 2026: The Possibilities of Aging and Health (Montreal, Canada)1. NOV 2026 - 3. NOV 2026Biology of Aging Symposium V 2026: The Possibilities of Aging and HealthConference - Montreal, Canada
  5. Atlas Cove Longevity Residency — November 2026 (Setúbal, Portugal)1. NOV 2026 - 6. NOV 2026Atlas Cove Longevity Residency — November 2026Retreat - Setúbal, Portugal

Latest in Longevity

|←←→
Longevity Technology23 Oct 2026
Immorta Bio’s nine-amino-acid peptide aims at zombie cells (Longevity Technology)

Immorta Bio’s nine-amino-acid peptide aims at zombie cells

Preclinical studies of SenoMune-0257 showed it recruits T cells to target senescent cells in models.

Key takeaways
  • SenoMune-0257 is reported to recruit T cells to senescent cells.
  • Human testing is planned for 2026, but details were unspecified.
  • Preclinical studies were completed but do not prove human efficacy.
Youtube — Siim Land23 Oct 2026
The New Tooth Regrowth Breakthrough You Need to Know About (Youtube — Siim Land)

The New Tooth Regrowth Breakthrough You Need to Know About

The speaker says TRG035 completed a Japanese phase 1 and is entering phase 2A for congenital tooth agenesis.

Key takeaways
  • The speaker reports that TRG035 is moving toward Phase 2A.
  • The speaker reports new tooth formation in animal experiments.
  • Human adult tooth regrowth remains unproven by these reported findings.
Longevity Technology23 Oct 2026
Big Pharma, clocks and clinics converge at 7th TimePie Forum (Longevity Technology)

Big Pharma, clocks and clinics converge at 7th TimePie Forum

Presenters linked aging clocks, regenerative trials and clinical longevity evidence needs in Shanghai.

Key takeaways
  • Trials showed biological changes, with limited patient functional gains.
  • Researchers presented new ageing measures and AI tissue analyses.
  • Longevity clinics are expanding while gaps in evidence remain.
BioSpace - Funding23 Oct 2026
Precisio Biotix Therapeutics Receives Additional Funding to Advance a New Approach to Bacterial Vaginosis (BV), A Major Women’s Health Issue (BioSpace - Funding

Precisio Biotix Therapeutics Receives Additional Funding to Advance a New Approach to Bacterial Vaginosis (BV), A Major Women’s Health Issue

Precisio received funding for engineered proteins targeting bacteria linked to bacterial vaginosis. The programme remains preclinical.

Key takeaways
  • This preclinical programme has not established benefits in patients.
  • The proteins are designed to target bacteria within biofilms.
  • The approach aims to preserve microbes considered beneficial.